Industry
Healthcare & Life Sciences
Target Company
Celsis In Vitro Technologies
Buyer/Investor
Bioreclamation, LLC
Client Description:
Celsis IVT is the premier global provider of specialized in vitro products for the study of metabolism, drug-drug interactions, and toxicity in drug discovery and development. Celsis IVT maintains the world’s largest inventory of cryopreserved hepatocytes, which in concert with the company’s patented LiverPoolTM technology, is an essential tool supporting ADME-Toxicity research. Celsis IVT is based in Baltimore, Maryland. For more information, please visit www.celsisivt.com.